Whether lung adenocarcinoma gene mutation is good or bad needs to depend on the direction of the gene mutation, i.e., the mutated gene, and whether there is any targeted therapeutic drug for it.
Lung adenocarcinoma gene mutation occurs with high probability. Generally speaking, after lung adenocarcinoma gene mutation, there may be one more choice in choosing targeted drugs, and targeted drug chemotherapy is better, with fewer side effects, and better tolerated compared with chemotherapy.
After some lung adenocarcinoma gene mutation, there is a target point that can be targeted for treatment, and applying corresponding drugs to treat this target point can greatly improve the effect of cancer treatment. In this case, lung adenocarcinoma gene mutation can be said to be a good thing.
Especially for patients with advanced lung adenocarcinoma, if targeted therapy can be used, it can effectively prolong the life span and prolong the survival period, and its quality of life can be improved accordingly.
If the mutated gene does not have targeted therapeutic drugs, then it is not considered a good thing.